Prostate Cancer News on BioPortfolio

Myriad Announces Seven New Payer Coverage Decisions for Prolaris

Myriad Genetics NASDAQMYGN a worldwide leader in personalized medicine today announced seven new commercial coverage decisions forÂProlaris the companys market leading prognostic test for patients with prostate cancer. ÂThe payers include a top25 commerci...

PSA Level Three Months After Radiation Tx May Predict Outcome

THURSDAY May 24 2018 Prostatespecific antigen PSA levels three months after radiotherapy RT are strong markers of prostate cancer outcomes for patients with intermediate and highrisk disease according to a study published online May 4...

Medical News Today Can saw palmetto reduce enlarged prostate

Saw palmetto is an herbal remedy with many potential uses in healthcare. One such use is the treatment of benign prostate hyperplasia BPH. Although a popular remedy research into the herbs efficacy is still ongoing and the results to date are inconclusive....

Sun Pharma Gets FDA GoAhead for Yonsa for Prostate Cancer

Sun Pharma received approval from the U.S. Food and Drug Administration FDA for Yonsa abiraterone acetate to treat metastatic castrationresistant prostate cancer mCRPC. Sun will launch the drug in the U.S. via a licensing deal with Churchill Pharmaceutical...

Pages